• Most Popular
  • Most Shared

Impotence drug treats prostate enlargement: study

WASHINGTON
Tue Aug 19, 2008 1:09am EDT
Two boxes with the new anti-impotence drug Cialis (tadafil) are pictured in a Munich pharmacy February 4, 2003. REUTERS/Michael Dalder

WASHINGTON (Reuters) - Impotence drugs may be able to help reduce the symptoms caused by enlarged prostates, such as trouble urinating, U.S. researchers reported on Tuesday.

Health

Men who took Eli Lilly and Co's Cialis every day had fewer symptoms, such as urinary frequency, urgency, intermittence, straining, incomplete emptying or a weak urinary stream, they reported in the journal Urology.

With about 50 percent of men over 50 suffering from some version of this problem, the study suggests a large potential market for erectile dysfunction drugs.

Researchers at the University of Texas Southwestern Medical Center at Dallas, Northwestern University in Chicago and Lilly Research Laboratories tested more than 1,000 men with enlarged prostates -- a condition known as benign prostatic hyperplasia or BPH.

Some got various doses of Cialis, known generically as tadalafil, while some got a placebo. Those who got Cialis were more likely to report their symptoms had improved, and a relatively low dose of 5 mg a day did the trick, reported the researchers, led by UTSW's Dr. Claus Roehrborn.

Cialis caused relatively few side effects, they added, in contrast to the drugs now used to treat BPH.

"Although they are effective, each of these drug classes can produce unwanted side effects, including dizziness, hypotension (low blood pressure) and sexual dysfunction," they wrote.

(Reporting by Maggie Fox; editing by Mohammad Zargham)



More from Reuters

An employee swipes a customer's credit card through the card reader at a restaurant in Tokyo February 19, 2005.REUTERS/Issei Kato

Taking a swipe at credit cards

New legislation meant to protect consumers could be a "game changer" for the industry -- and not in a good way.  Full Article 

 dealer shuffles a deck of cards during a poker game at a casino in Budapest September 15, 2009.  REUTERS/Katoly Arvai

Placing their bets

Two IPO filings will test investors' appetite for risk that they probably would've avoided in the past year.  Full Article